Trenders, Inc. (TSE:6069) agreed to acquire CLEMENCE·LABORATORY, Inc. from Kanae Hirano for CNY 29.6 million on December 24, 2021. The consideration comprises of cash payment of CNY 21.65 million and issuance of 10,000 shares of Trenders valued at CNY 8.35 million. After the issuance of the shares, Hirano will continue to serve as Representative Director of CLEMENCE.

The CLEMENCE·LABORATORY will change its location and accounting period as follows after the share delivery becomes effective. In addition, the company's trade name, title / name of representative, business content and capital stock will change due to the share delivery. As of January 31, 2021, CLEMENCE·LABORATORY had net assets of ¥0.973 million and total assets of ¥4.4 million.

For the year ending January 31, 2021, CLEMENCE·LABORATORY had revenues of ¥5.3 million and net income of ¥0.717 million. The transaction is expected to close on February 7, 2022.